Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Anaptysbio (ANAB) Non Operating Income (2016 - 2025)

Anaptysbio's Non Operating Income history spans 10 years, with the latest figure at -$66.4 million for Q4 2025.

  • For Q4 2025, Non Operating Income fell 447.83% year-over-year to -$66.4 million; the TTM value through Dec 2025 reached -$110.2 million, down 263.8%, while the annual FY2025 figure was -$61.0 million, 101.34% down from the prior year.
  • Non Operating Income reached -$66.4 million in Q4 2025 per ANAB's latest filing, down from -$19.6 million in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $788000.0 in Q4 2023 to a low of -$66.4 million in Q4 2025.
  • Average Non Operating Income over 5 years is -$7.2 million, with a median of -$4000.0 recorded in 2022.
  • Peak YoY movement for Non Operating Income: skyrocketed 19800.0% in 2023, then crashed 1009500.0% in 2024.
  • A 5-year view of Non Operating Income shows it stood at $1000.0 in 2021, then crashed by 500.0% to -$4000.0 in 2022, then surged by 19800.0% to $788000.0 in 2023, then plummeted by 1638.07% to -$12.1 million in 2024, then tumbled by 447.83% to -$66.4 million in 2025.
  • Per Business Quant, the three most recent readings for ANAB's Non Operating Income are -$66.4 million (Q4 2025), -$19.6 million (Q3 2025), and -$12.4 million (Q2 2025).